Recurrence of Myopericarditis Following mRNA COVID-19 Vaccination in a Male Adolescent

Tomohiko C. Umei; Yoshikazu Kishino; Keiko Watanabe; Yasuyuki Shiraishi; Taku Inohara; Shinsuke Yuasa; Keiichi Fukuda

doi:10.1016/j.cjco.2021.12.002

Recurrence of Myopericarditis Following mRNA COVID-19 Vaccination in a Male Adolescent

Tomohiko C. Umei, Yoshikazu Kishino, Keiko Watanabe, Yasuyuki Shiraishi, Taku Inohara, Shinsuke Yuasa, Keiichi Fukuda

内科学(循環器)

研究成果: Article › 査読

11 被引用数 (Scopus)

抄録

COVID-19 is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The disease has spread worldwide, resulting in health and economic crises. Vaccination against SARS-CoV-2 infection is considered a valid prevention measure to control this pandemic. There have been reports of cases of myopericarditis following mRNA COVID-19 vaccination. We present a case of a 20-year-old man with recurrent myopericarditis following an initial episode of influenza virus–induced myopericarditis and after a second dose of the mRNA-1273 Moderna COVID-19 vaccine. Careful attention should be paid to patients with a history of myocarditis following COVID-19 vaccination.

本文言語	English
ページ（範囲）	350-352
ページ数	3
ジャーナル	CJC Open
巻	4
号	3
DOI	https://doi.org/10.1016/j.cjco.2021.12.002
出版ステータス	Published - 2022 3月

ASJC Scopus subject areas

循環器および心血管医学

UN SDG

この成果は、次の持続可能な開発目標に貢献しています

文献へのアクセス

10.1016/j.cjco.2021.12.002

他のファイルとリンク

引用スタイル

@article{6bfb7e6a35794cf8bdf26be29cb45997,

title = "Recurrence of Myopericarditis Following mRNA COVID-19 Vaccination in a Male Adolescent",

abstract = "COVID-19 is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The disease has spread worldwide, resulting in health and economic crises. Vaccination against SARS-CoV-2 infection is considered a valid prevention measure to control this pandemic. There have been reports of cases of myopericarditis following mRNA COVID-19 vaccination. We present a case of a 20-year-old man with recurrent myopericarditis following an initial episode of influenza virus–induced myopericarditis and after a second dose of the mRNA-1273 Moderna COVID-19 vaccine. Careful attention should be paid to patients with a history of myocarditis following COVID-19 vaccination.",

author = "Umei, {Tomohiko C.} and Yoshikazu Kishino and Keiko Watanabe and Yasuyuki Shiraishi and Taku Inohara and Shinsuke Yuasa and Keiichi Fukuda",

note = "Funding Information: The authors have no sources of funding to declare. The authors have no conflicts of interest to disclose. Publisher Copyright: {\textcopyright} 2021 The Authors",

year = "2022",

month = mar,

doi = "10.1016/j.cjco.2021.12.002",

language = "English",

volume = "4",

pages = "350--352",

journal = "CJC Open",

issn = "2589-790X",

publisher = "Elsevier Inc.",

number = "3",

}

TY - JOUR

T1 - Recurrence of Myopericarditis Following mRNA COVID-19 Vaccination in a Male Adolescent

AU - Umei, Tomohiko C.

AU - Kishino, Yoshikazu

AU - Watanabe, Keiko

AU - Shiraishi, Yasuyuki

AU - Inohara, Taku

AU - Yuasa, Shinsuke

AU - Fukuda, Keiichi

PY - 2022/3

Y1 - 2022/3

N2 - COVID-19 is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The disease has spread worldwide, resulting in health and economic crises. Vaccination against SARS-CoV-2 infection is considered a valid prevention measure to control this pandemic. There have been reports of cases of myopericarditis following mRNA COVID-19 vaccination. We present a case of a 20-year-old man with recurrent myopericarditis following an initial episode of influenza virus–induced myopericarditis and after a second dose of the mRNA-1273 Moderna COVID-19 vaccine. Careful attention should be paid to patients with a history of myocarditis following COVID-19 vaccination.

AB - COVID-19 is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The disease has spread worldwide, resulting in health and economic crises. Vaccination against SARS-CoV-2 infection is considered a valid prevention measure to control this pandemic. There have been reports of cases of myopericarditis following mRNA COVID-19 vaccination. We present a case of a 20-year-old man with recurrent myopericarditis following an initial episode of influenza virus–induced myopericarditis and after a second dose of the mRNA-1273 Moderna COVID-19 vaccine. Careful attention should be paid to patients with a history of myocarditis following COVID-19 vaccination.

UR - http://www.scopus.com/inward/record.url?scp=85124020026&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85124020026&partnerID=8YFLogxK

U2 - 10.1016/j.cjco.2021.12.002

DO - 10.1016/j.cjco.2021.12.002

M3 - Article

AN - SCOPUS:85124020026

SN - 2589-790X

VL - 4

SP - 350

EP - 352

JO - CJC Open

JF - CJC Open

IS - 3

ER -

Recurrence of Myopericarditis Following mRNA COVID-19 Vaccination in a Male Adolescent

抄録

ASJC Scopus subject areas

UN SDG

文献へのアクセス

他のファイルとリンク

フィンガープリント

引用スタイル